|
|
|
|
|
|
|
16.06.26 - 19:03
|
Inszone Insurance Services Acquires Sanford, Bruker & Banks, Inc., Adding Over a Century of Experience to Its Roster (Business Wire)
|
|
|
SACRAMENTO, Calif.--(BUSINESS WIRE)--#agencyacquisition--Inszone Insurance Services, a rapidly growing national provider of commercial, personal, and benefits insurance, is pleased to announce the acquisition of Sanford, Bruker & Banks, Inc., a historic independent insurance agency with roots dating back to 1915.
Founded over a century ago by Davenport Sanford, the agency has spent the last 111 years protecting families and businesses through world events, economic shifts, and massive industry changes. Sanford, Bruker & Banks has stood as a pillar of reliability for generations of clients. Under the leadership of current owner Jeffrey Banks, the agency has continued this incredible legacy, operating as a trusted generalist while developing a strong specialization in serving small and artisan contractors.
At 73 years old, Banks recognized the vital importance of succession planning. He wanted to ensure the agency's long-standing legacy would be protected.
"When you have a business that has been serving th...
|
|
|
09.06.26 - 14:06
|
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company's new Chief Financial Officer, effective June 22. Faessler brings extensive finance leadership experience and expertise in managing complex organizations in the life science tools industry, positioning him to play a pivotal role in executing Quanterix's strategic growth plans in the coming years.
“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations makes him the ideal leader to support our ambitious growth objectives. Jason's expertise in strategic financial and capital planning, operational excellence, and commercial support will be instrumental in advancing our mission.”
Faessler joins Quanterix from Bruker Corporat...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.05.26 - 12:36
|
Bruker Reports First Quarter 2026 Financial Results (Business Wire)
|
|
|
Q1 2026 revenues of $823.4 million, up 2.7% year-over-year (yoy), down 4.4% organically
Q1-26 GAAP diluted earnings per share (EPS) $0.02; non-GAAP diluted EPS $0.31
Q1-26 Bruker Scientific Instruments (BSI) bookings up high-single digits % organically yoy; BSI book-to-bill ratio above 1.0x for 3rd consecutive quarter
Reconfirming previous FY2026 guidance:
Revenues of $3.57 to $3.60 billion, up 4% to 5% yoy, with organic growth of 1% to 2%
Non-GAAP EPS of $2.10 to $2.15, up 15% to 17% yoy, including an ~8% FX headwind
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three months ended March 31, 2026.
Frank H. Laukien, Bruker's President and CEO, commented: “While US academic demand, tariff and currency headwinds still pressured our first quarter results, our Q1 financial performance came in ahead of expectations. We are encouraged that our first quarter BSI segment bookings grew organically at a high single digit percentage, and...
|
|
|
|
|
|
|
24.04.26 - 13:03
|
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2026 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702 (international) and referencing “Bruker's First Quarter 2026 Earnings Conference Call.”
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call and avoid the need to wait for a...
|
|
|
|
|
|
|
|
|
01.04.26 - 13:03
|
Bruker Announces Appointment of Thierry Bernard to its Board of Directors (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience.
Frank H. Laukien, the Chairman, President and CEO of Bruker Corporation, stated: “Bruker is delighted that Thierry is joining our Board. I have admired his successful track record, astute strategic initiatives, and outstanding execution for many years, and I am convinced that Thierry will be an excellent addition to our Board of Directors as we further develop our leadership position in life-science research, biopharma, and diagnostic solutions in the post-genomic era, and aim for profitable growth and rapid margin expansion to enhance stakeholder value.”
Mr. Bernard currently serves as Chief Executive Officer of QIAGEN N.V. He joined QIAGEN in 2015 to l...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
